resiquimod has been researched along with rgfp966 in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (rgfp966) | Trials (rgfp966) | Recent Studies (post-2010) (rgfp966) |
---|---|---|---|---|---|
465 | 14 | 318 | 51 | 0 | 49 |
Protein | Taxonomy | resiquimod (IC50) | rgfp966 (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.14 | |
Histone deacetylase 1 | Homo sapiens (human) | 5.6 | |
Histone deacetylase 2 | Homo sapiens (human) | 9.7 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for resiquimod and rgfp966
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |